Elahna Paul

1.8k total citations
31 papers, 1.3k citations indexed

About

Elahna Paul is a scholar working on Immunology, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Elahna Paul has authored 31 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 9 papers in Physiology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Elahna Paul's work include T-cell and B-cell Immunology (10 papers), Tuberous Sclerosis Complex Research (8 papers) and Renal cell carcinoma treatment (5 papers). Elahna Paul is often cited by papers focused on T-cell and B-cell Immunology (10 papers), Tuberous Sclerosis Complex Research (8 papers) and Renal cell carcinoma treatment (5 papers). Elahna Paul collaborates with scholars based in United States, United Kingdom and Russia. Elahna Paul's co-authors include Elizabeth A. Thiele, Elkan F. Halpern, David Steele, Betty Diamond, Michael C. Carroll, Cynthia Aranow, Matthew D. Scharff, Jessica Katz, Daniel L. Lustgarten and Betty Diamond and has published in prestigious journals such as New England Journal of Medicine, Nature Medicine and Nature Communications.

In The Last Decade

Elahna Paul

30 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elahna Paul United States 18 515 465 386 383 258 31 1.3k
Yoshikata Misaki Japan 19 295 0.6× 809 1.7× 112 0.3× 221 0.6× 77 0.3× 38 1.3k
Hajime Yamagata Japan 16 327 0.6× 437 0.9× 160 0.4× 347 0.9× 399 1.5× 35 1.5k
C de la Salle France 19 159 0.3× 407 0.9× 99 0.3× 245 0.6× 214 0.8× 30 1.3k
Aishwarya Ravindran United States 18 438 0.9× 452 1.0× 342 0.9× 336 0.9× 42 0.2× 65 1.6k
J Breton-Gorius France 18 207 0.4× 339 0.7× 264 0.7× 474 1.2× 51 0.2× 64 1.6k
Maria I. Zervou Greece 22 68 0.1× 666 1.4× 134 0.3× 235 0.6× 83 0.3× 88 1.3k
Ghislaine Bernard France 20 73 0.1× 523 1.1× 379 1.0× 511 1.3× 81 0.3× 28 1.5k
NN Iscove Canada 16 269 0.5× 491 1.1× 102 0.3× 444 1.2× 100 0.4× 20 1.5k
J B Harley United States 17 203 0.4× 581 1.2× 36 0.1× 147 0.4× 275 1.1× 23 1.1k
Christopher G. Przybycin United States 20 197 0.4× 127 0.3× 855 2.2× 676 1.8× 29 0.1× 56 1.5k

Countries citing papers authored by Elahna Paul

Since Specialization
Citations

This map shows the geographic impact of Elahna Paul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elahna Paul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elahna Paul more than expected).

Fields of papers citing papers by Elahna Paul

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elahna Paul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elahna Paul. The network helps show where Elahna Paul may publish in the future.

Co-authorship network of co-authors of Elahna Paul

This figure shows the co-authorship network connecting the top 25 collaborators of Elahna Paul. A scholar is included among the top collaborators of Elahna Paul based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elahna Paul. Elahna Paul is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Danpanichkul, Pojsakorn, Alberto Hayek, Elahna Paul, et al.. (2025). Artificial Intelligence in Gastroenterology Education: DeepSeek Passes the Gastroenterology Board Examination and Outperforms Legacy ChatGPT Models. The American Journal of Gastroenterology.
2.
Bradley, Robert L., Elahna Paul, Sharda P. Singh, & Thomas E. Hutson. (2025). CD70-targeted allogeneic CAR T-cell therapy for clear cell renal cell carcinoma. Expert Review of Anticancer Therapy. 25(11). 1275–1284. 1 indexed citations
3.
Kilcoyne, Aoife, et al.. (2022). Cystic kidney disease in tuberous sclerosis complex: current knowledge and unresolved questions. Pediatric Nephrology. 38(10). 3253–3264. 10 indexed citations
4.
Sheth, Rahul A., Adam S. Feldman, Elahna Paul, Elizabeth A. Thiele, & T. Gregory Walker. (2016). Angiographic and volumetric effects of mammalian target of rapamycin inhibitors on angiomyolipomas in tuberous sclerosis. World Journal of Radiology. 8(3). 308–308. 11 indexed citations
5.
Sheth, Rahul A., Adam S. Feldman, Elahna Paul, Elizabeth A. Thiele, & T. Gregory Walker. (2016). Sporadic versus Tuberous Sclerosis Complex–Associated Angiomyolipomas: Predictors for Long-Term Outcomes following Transcatheter Embolization. Journal of Vascular and Interventional Radiology. 27(10). 1542–1549. 18 indexed citations
6.
Acharya, Mridu, Anna Sokolovska, Jenny M. Tam, et al.. (2016). αv Integrins combine with LC3 and atg5 to regulate Toll-like receptor signalling in B cells. Nature Communications. 7(1). 10917–10917. 50 indexed citations
7.
Yang, Ping, Kristine M. Cornejo, Peter M. Sadow, et al.. (2014). Renal Cell Carcinoma in Tuberous Sclerosis Complex. The American Journal of Surgical Pathology. 38(7). 895–909. 178 indexed citations
8.
Camposano, Susana, et al.. (2012). Hepatic manifestations of tuberous sclerosis complex: a genotypic and phenotypic analysis. Clinical Genetics. 82(6). 552–557. 25 indexed citations
9.
Paul, Elahna, Elizabeth A. Thiele, Randheer Shailam, A.M. Rosales, & Peter M. Sadow. (2011). Case 26-2011. New England Journal of Medicine. 365(8). 743–751. 6 indexed citations
10.
Feliu, Marianela, Martin K. Selig, Yvette Latchman, et al.. (2011). The SLAM family member CD48 (Slamf2) protects lupus-prone mice from autoimmune nephritis. Journal of Autoimmunity. 37(1). 48–57. 22 indexed citations
11.
Keszei, Márton, Yvette Latchman, Vijay K. Vanguri, et al.. (2011). Auto-antibody production and glomerulonephritis in congenic Slamf1-/- and Slamf2-/- [B6.129] but not in Slamf1-/- and Slamf2-/- [BALB/c.129] mice. International Immunology. 23(2). 149–158. 21 indexed citations
12.
Paul, Elahna, Kerry D. Conant, Heidi H. Pfeifer, et al.. (2010). Urolithiasis on the ketogenic diet with concurrent topiramate or zonisamide therapy. Epilepsy Research. 90(1-2). 151–156. 34 indexed citations
13.
Paul, Elahna, et al.. (2006). Renal manifestations of tuberous sclerosis complex: Incidence, prognosis, and predictive factors. Kidney International. 70(10). 1777–1782. 332 indexed citations
14.
Paul, Elahna. (2004). Germinal center checkpoints in B cell tolerance in 3H9 transgenic mice. International Immunology. 16(2). 377–384. 26 indexed citations
15.
Paul, Elahna, et al.. (2002). Anti-DNA autoreactivity in C4-deficient mice. European Journal of Immunology. 32(9). 2672–2679. 59 indexed citations
16.
Paul, Elahna, Scott Van Why, & Thomas O. Carpenter. (1999). Hyperthyroidism: A Novel Feature of the Tubulointerstitial Nephritis and Uveitis Syndrome. PEDIATRICS. 104(2). 314–317. 29 indexed citations
17.
Paul, Elahna & Prasad Devarajan. (1998). Mycobacterium phlei peritonitis: a rare complication of chronic peritoneal dialysis. Pediatric Nephrology. 12(1). 67–68. 20 indexed citations
18.
Paul, Elahna, et al.. (1992). The anti-DNA-associated idiotype 8.12 is encoded by the V lambda II gene family and maps to the vicinity of L chain CDR1. The Journal of Immunology. 149(11). 3588–3595. 39 indexed citations
19.
Diamond, Betty, Jessica Katz, Elahna Paul, et al.. (1992). The Role of Somatic Mutation in the Pathogenic Anti-DNA Response. Annual Review of Immunology. 10(1). 731–757. 203 indexed citations
20.
Paul, Elahna, A Manheimer-Lory, Avi Livneh, et al.. (1990). Pathogenic Anti-DNA Antibodies in SLE: Idiotypic Families and Genetic Origins. International Reviews of Immunology. 5(3-4). 295–313. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshikata Misaki Breakdown of academic impact, for papers by Hajime Yamagata Breakdown of academic impact, for papers by C de la Salle Breakdown of academic impact, for papers by Aishwarya Ravindran Breakdown of academic impact, for papers by J Breton-Gorius Breakdown of academic impact, for papers by Maria I. Zervou Breakdown of academic impact, for papers by Ghislaine Bernard Breakdown of academic impact, for papers by NN Iscove Breakdown of academic impact, for papers by J B Harley Breakdown of academic impact, for papers by Christopher G. Przybycin
Rankless by CCL
2026